Skip to main content
MTEX
NASDAQ Life Sciences

Nasdaq Issues Delisting Notice to Mannatech Over Sub-Minimum Stockholders' Equity

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Household Product Stocks · Consumer
Sentiment info
Negative
Importance info
9
Price
$4.7
Mkt Cap
$9.185M
52W Low
$4.665
52W High
$12.454
52W Position info
0.8% above low
Off High info
62% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

MTEX is trading near its 52-week low of $4.665 (0.8% above the low).

Summary

Mannatech received a Nasdaq delisting notice for failing to meet minimum stockholders' equity requirements, escalating concerns about its financial viability and stock market listing.


Key Events · Legal and Risk Events · MTEX

  • Nasdaq Delisting Notice Received

    Mannatech was notified by Nasdaq of non-compliance with Listing Rule 5550(b)(1), requiring minimum stockholders' equity of $2.5 million.

  • Significant Equity Deficiency

    As of December 31, 2025, the company reported a stockholders' equity deficit of ($5,223,000), falling approximately $7.7 million below the Nasdaq requirement.

  • Compliance Plan Required

    The company has 45 days (until June 4, 2026) to submit a plan to regain compliance, with a potential extension of up to 180 days.

  • Listing at Risk

    Failure to regain compliance could lead to delisting from the Nasdaq Capital Market, although the notice does not result in immediate delisting.


Analysis · MTEX · Life Sciences

This 8-K reports a critical development for Mannatech, as Nasdaq has issued a formal notice of non-compliance due to the company's failure to meet the minimum stockholders' equity requirement of $2.5 million. The company's reported deficit of $5.223 million as of December 31, 2025, directly triggered this notice. While the underlying financial distress was disclosed in the recent 10-K, this formal notice escalates the risk, threatening the company's listing on the Nasdaq Capital Market. The company has 45 days to submit a compliance plan, but there is no guarantee of acceptance or successful remediation. This event, coupled with the prior going concern warning and negative financial results, significantly increases the investment risk and could further pressure the stock, which is already trading near its 52-week low.

At the time of this filing, MTEX was trading at $4.70 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $9.2M. The 52-week trading range was $4.67 to $12.45. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MTEX - Latest Insights

MTEX
Jun 08, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.63
Real-time Price: $4.50 info
Change: -$1.13 (-20%) info
Market Cap: $8.684M info
MTEX
May 20, 2026, 2:37 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $3.98
Real-time Price: $4.50 info
Change: +$0.520 (+13%) info
Market Cap: $8.684M info
MTEX
May 14, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.62
Real-time Price: $4.50 info
Change: -$0.120 (-3%) info
Market Cap: $8.684M info
MTEX
May 14, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $4.62
Real-time Price: $4.50 info
Change: -$0.120 (-3%) info
Market Cap: $8.684M info
MTEX
May 14, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $4.62
Real-time Price: $4.50 info
Change: -$0.120 (-3%) info
Market Cap: $8.684M info